SPRY
ARS Pharmaceuticals, Inc.Company with tickers: SPRY
CIK
1671858
CUSIP
82835W108
Shares Outstanding
99,303,262
Website
https://ars-pharma.com
13F Activity (30d)
4 filings
3 filers
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
No Compensation Data
No Summary Compensation Table has been imported from this company's proxy statements yet.
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Donn Casale | President | Appointed | 2026-05-13 |